Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
LYEL on Nasdaq
Charles W. Newton - trading volume in the past year for Lyell Immunopharma, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
200K |
$112K |
$0.56 |
Mar 17, 2025 |
Co-grantor and Co-trustee |
|
|
| Common Stock |
173K |
$96.4K |
$0.56 |
Mar 17, 2025 |
Direct |
|
|
| Option (right to buy) |
56.3K |
|
|
Feb 10, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.